Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ADCETRIS

BRENTUXIMAB VEDOTIN

Standard Dose
50MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview ADCETRIS is listed in Drugs@FDA under application 125399 (BLA).

Marketing status: Prescription Active ingredient BRENTUXIMAB VEDOTIN Form and strength INJECTABLE; INJECTION - 50MG/VIAL Sponsor SEATTLE GENETICS Submission history Latest submission status date: 2011-08-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ADCETRIS is listed in Drugs@FDA under application 125399 (BLA). Marketing status: Prescription Active ingredient BRENTUXIMAB VEDOTIN Form and strength INJECTABLE; INJECTION - 50MG/VIAL Sponsor SEATTLE GENETICS Submission history Latest submission status date: 2011-08-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.